Link between plasma ceramides, inflammation and insulin resistance: Association with serum IL-6 concentration in patients with coronary heart disease

Diabetologia

Volumn 52, Issue 12, 2009, Pages 2612-2615

  De Mello, V D F ^a   Lankinen, M ^a,b   Schwab, U ^a,c   Kolehmainen, M ^a   Lehto, S ^c   Seppanen Laakso T ^b   Oresic M ^b   Pulkkinen, L ^a   Uusitupa, M ^a   Erkkila A T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cardiovascular disease; Ceramides; Diacylglycerols; IL 6; Inflammation; Insulin resistance; Lipidomics

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CERAMIDE; CYTOKINE; DIACYLGLYCEROL; GLUCOSE; INSULIN; INTERLEUKIN 6; LIPID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIETARY INTAKE; DISEASE ASSOCIATION; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FINLAND; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; LIPIDOMICS; LIQUID CHROMATOGRAPHY; METABOLITE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA; PRIORITY JOURNAL; SERUM; STATISTICAL SIGNIFICANCE;

C-REACTIVE PROTEIN; CERAMIDES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN-6; ISCHEMIA; LIPIDS; MYOCARDIAL INFARCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70949101414     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1482-9     Document Type: Article

References (14)

1. SA Summers 2006 Ceramides in insulin resistance and lipotoxicity Prog Lipid Res 45 42 72 10.1016/j.plipres.2005.11.002 1:CAS:528:DC%2BD28XhtV2ksbg%3D 16445986 (Pubitemid 43170804)
2. LF van Gaal IL Mertens CE de Block 2006 Mechanisms linking obesity with cardiovascular disease Nature 444 875 880 10.1038/nature05487 17167476 (Pubitemid 46028447)
3. DE Laaksonen L Niskanen K Nyyssonen, et al.. 2004 C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men Diabetologia 47 1403 1410 10.1007/s00125-004-1472-x 1:CAS:528: DC%2BD2cXmtlyltro%3D 15309290 (Pubitemid 39232426)
4. AD Pradhan PM Ridker 2002 Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J 23 831 834 10.1053/euhj.2001.3052 1:CAS:528:DC%2BD38XlslCmsLo%3D 12042000 (Pubitemid 34717414)
5. WL Holland TA Knotts JA Chavez LP Wang KL Hoehn SA Summers 2007 Lipid mediators of insulin resistance Nutr Rev 65 S39 S46 10.1111/j.1753-4887.2007. tb00327.x 17605313
6. P Bressler SR Bailey M Matsuda RA DeFronzo 1996 Insulin resistance and coronary artery disease Diabetologia 39 1345 1350 10.1007/s001250050581 1:CAS:528:DyaK28XmvFCjtrk%3D 8933003 (Pubitemid 26356065)
7. AT Erkkilä US Schwab VD de Mello, et al.. 2008 Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications Eur J Nutr 47 319 328 10.1007/s00394-008-0728-5 18665413
8. M Lankinen US Schwab AT Erkkilä, et al.. 2009 Fatty fish intake decreases lipids related to inflammation and insulin signaling-a lipidomics approach PLoS ONE 4 e5258 10.1371/journal.pone.0005258 19390588
9. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D 3899825 (Pubitemid 15018832)
10. JM Haus SR Kashyap T Kasumov, et al.. 2009 Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance Diabetes 58 337 343 10.2337/db08-1228 1:CAS:528: DC%2BD1MXhslersLY%3D 19008343
11. D Wu M Marko K Claycombe KE Paulson SN Meydani 2003 Ceramide-induced and age-associated increase in macrophage COX-2 expression is mediated through up-regulation of NF-κ B activity J Biol Chem 278 10983 10992 10.1074/jbc.M207470200 1:CAS:528:DC%2BD3sXit1Khu7k%3D 12529332 (Pubitemid 36792646)
12. W Vanden Berghe L Vermeulen G de Wilde K de Bosscher E Boone G Haegeman 2000 Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6 Biochem Pharmacol 60 1185 1195 10.1016/S0006-2952(00)00412-3 1:CAS:528:DC%2BD3cXmslOjtr0%3D 11007957
13. M Yuan N Konstantopoulos J Lee, et al.. 2001 Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ Science 293 1673 1677 10.1126/science.1061620 1:CAS:528: DC%2BD3MXms1Chtrw%3D 11533494 (Pubitemid 32807849)
14. S Devaraj SK Venugopal U Singh I Jialal 2005 Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase C-α and -β Diabetes 54 85 91 10.2337/diabetes.54.1.85 1:CAS:528: DC%2BD2MXhtVWjurc%3D 15616014 (Pubitemid 40105098)